Skip to main content
Premium Trial:

Request an Annual Quote

Cofactor Genomics, Novocraft Technologies Partner in Southeast Asia

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The sequencing service provider Cofactor Genomics and the bioinformatics company Novocraft Technologies plan to partner to offer sequencing and analysis services in Southeast Asia, Cofactor announced today.

Through the partnership, St. Louis-based Cofactor will offer sequencing services in Southeast Asia and Kuala Lumpur-based Novocraft will provide analyses to support this sequencing effort.

Cofactor, which launched in 2008, uses Illumina and Applied Biosystems sequencing technology combined with commercial and proprietary analysis software, while Novocraft develops novel algorithms for analyzing high throughput sequencing data.

"Southeast Asia is an important emerging market for genome sequencing and analysis and Novocraft's influence in that region will play a fundamental role in helping Cofactor reach our goals," Jon Armstrong, chief marketing officer for Cofactor, said in a statement, noting that the company is already using some Novocraft tools in-house.

The Scan

Panel Recommends Pfizer-BioNTech Vaccine for Kids

CNN reports that the US Food and Drug Administration advisory panel has voted in favor of authorizing the Pfizer-BioNTech SARS-CoV-2 vaccine for children between 5 and 11 years old.

Sharing How to Make It

Merck had granted a royalty-free license for its COVID-19 treatment to the Medicines Patent Pool, according to the New York Times.

Bring it Back In

Bloomberg reports that a genetic analysis has tied a cluster of melioidosis cases in the US to a now-recalled aromatherapy spray.

Nucleic Acids Research Papers on SomaMutDB, VThunter, SCovid Databases

In Nucleic Acids Research this week: database of somatic mutations in normal tissue, viral receptor-related expression signatures, and more.